Rankings
▼
Calendar
KLRS Q4 2023 Earnings — Kalaris Therapeutics Inc Revenue & Financial Results | Market Cap Arena
KLRS
Kalaris Therapeutics Inc
$187M
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3M
Net Income
-$3M
EPS (Diluted)
$-0.70
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$31,000
Balance Sheet
Total Assets
$3M
Total Liabilities
$48M
Stockholders' Equity
-$45M
Cash & Equivalents
$3M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$1M
+100.0%
Operating Income
-$3M
-$40M
+91.4%
Net Income
-$3M
-$38M
+90.9%
← FY 2023
All Quarters
Q1 2024 →